Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy? | Zendy

Mustafa A. Altaha | Zendy; Mark Nolan | Zendy; Thomas H. Marwick | Zendy; Emily Somerset | Zendy; Christian Houbois | Zendy; Eitan Amir | Zendy; Paul S. F. Yip | Zendy; Kim A. Connelly | Zendy; Maria Michalowska | Zendy; Marshall S. Sussman | Zendy; Bernd J. Wintersperger | Zendy; Paaladinesh Thavendiranathan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy?

Author(s) -

Mustafa A. Altaha,

Mark Nolan,

Thomas H. Marwick,

Emily Somerset,

Christian Houbois,

Eitan Amir,

Paul S. F. Yip,

Kim A. Connelly,

Maria Michalowska,

Marshall S. Sussman,

Bernd J. Wintersperger,

Paaladinesh Thavendiranathan

Publication year - 2019

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2019.10.016

Subject(s) - cardiotoxicity , medicine , chemotherapy , cardiology

The purpose of this study was to investigate the effect of the temporal and observer variability of cardiac magnetic resonance (CMR)-measured native T 1 , T 2 , and extracellular volume fraction (ECV) and serum biomarkers for the detection of cancer-therapeutics-related cardiac dysfunction (CTRCD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research